The actual status of drug prices and adjustment factors for drug price calculation: an analysis of ultra-orphan drug development in Japan

BACKGROUND: Extremely high prices facilitate drug development for ultra-rare diseases (ultra-orphan drugs). However, various problems arise in terms of healthcare financing and fairness, and the status of ultra-orphan drug pricing remains ambiguous. In this study, we investigated ultra-orphan drug p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Akihiko, Masamune, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641848/
https://www.ncbi.nlm.nih.gov/pubmed/36348359
http://dx.doi.org/10.1186/s13023-022-02526-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641848/
https://www.ncbi.nlm.nih.gov/pubmed/36348359
http://dx.doi.org/10.1186/s13023-022-02526-z

Ejemplares similares